A previous study revealed GAS5 levels to be consistently reduced in human AD brain samples, and furthermore that depletion of GAS5 decreases insulin signaling in neurons and increases phosphorylated tau, which influences synaptic dysfunction in tauopathies [79]. Here, MAPT is linked to Alzheimer disease.